Lebanon, NH, United States of America

Benjamine H Arellano

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Benjamine H. Arellano

Introduction: Benjamine H. Arellano is an innovative inventor based in Lebanon, NH, specializing in cutting-edge research aimed at combating inflammation and immune-mediated autoimmunity. With one patent to his name, he is a notable contributor to the field of immunology.

Latest Patents: Arellano's noteworthy patent is titled "Chimeric antigen receptor anti-inflammatory cells and methods of use." This invention focuses on a nucleic acid construct and an immune cell that incorporates nucleic acids encoding a chimeric antigen receptor (CAR) alongside nucleic acids for at least one anti-inflammatory or immunosuppressant protein. The patent details methods for utilizing these constructs in the treatment and amelioration of inflammatory conditions and immune-mediated diseases.

Career Highlights: Benjamine H. Arellano currently serves as an influential researcher at Dartmouth College, where he engages in extensive academic and practical research. His work is characterized by a commitment to addressing significant health issues related to inflammation, showcasing his dedication and expertise in the field.

Collaborations: Throughout his career, Arellano has worked closely with Charles L. Sentman, a fellow researcher whose collaborative efforts have further bolstered the innovative landscape of their shared research initiatives. This partnership underscores the importance of teamwork in advancing medical research and fostering scientific breakthroughs.

Conclusion: Benjamine H. Arellano's contributions to the field of immunology, particularly through his patented invention, highlight the critical role of innovation in healthcare. As research continues to evolve, his efforts at Dartmouth College will undoubtedly pave the way for new treatments and improve outcomes for individuals suffering from inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…